Ocular Adverse Events of Antibody Drug Conjugates and Association With Survival From a Real-World Database

Uveitis and corneal ulcers were exceedingly rare for all ADCs. Patients on ADCs with ocular adverse events, compared with those without, had a decreased risk of death. As ophthalmologic management of patients on ADCs are becoming more prevalent, aggressive management of ocular adverse events may be warranted, when ADCs are effective, as ocular adverse events may portend better survival outcomes.